L. Becker Hewes, CHIEF MEDICAL OFFICER at Blueprint Medicines Corp (BPMC), sold 78,060 shares at $106.50 ($8.3M) on 2024-05-31, disclosed to the SEC on 2024-06-04.
Scheduled sale ($8.3M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.83 | 6,342 | $665K | 8.0% |
| 2 | $104.83 | 6,342 | $665K | 8.0% |
| 3 | $105.81 | 20,904 | $2.2M | 26.7% |
| 4 | $105.81 | 20,904 | $2.2M | 26.7% |
| 5 | $106.50 | 3,191 | $340K | 4.1% |
| 6 | $106.50 | 3,191 |
| $340K |
| 4.1% |
| 7 | $107.86 | 3,671 | $396K | 4.8% |
| 8 | $107.86 | 3,671 | $396K | 4.8% |
| 9 | $106.43 | 1,951 | $208K | 2.5% |
| 10 | $106.43 | 1,951 | $208K | 2.5% |
| 11 | $106.43 | 2,971 | $316K | 3.8% |
| 12 | $106.43 | 2,971 | $316K | 3.8% |
| Total | $105.98 avg | 78,060 | $8.3M | 100% |
| Filing → |
| BPMC | SELL | 2024-03-11 | $562K | — | Filing → |
| BPMC | SELL | 2023-06-07 | $146K | — | Filing → |
| BPMC | SELL | 2023-03-08 | $136K | — | Filing → |